'Providing more than world-class hematopathology services, Miraca Life Sciences is experienced in collaborating with hematology and oncology practices to develop, implement and integrate technology solutions,' said Dan Kelly
Irving, Texas (PRWEB) May 20, 2014
Miraca Life Sciences, (MLS) the nation’s largest independent anatomic pathology lab, will announce new services for oncology practices at the 50th annual meeting of the American Society of Clinical Oncology (ASCO).
Visitors to Miraca Life Science’s tradeshow booth #8123 can learn about new technology partnerships and product offerings, including a new strategic collaboration with Physician Resource Management (PRM) that will enable Miraca Life Sciences to serve as the preferred hematology oncology reference laboratory for PRM. The collaboration of the two organizations is poised to deliver a specialized solution to enhance oncology care and therapy management for the nation’s patient and practice population.
In addition, attendees to Miraca Life Sciences’ booth can learn how MLS can help practices to incorporate smart business solutions such as the Flow Cytometry Lab Partnership Program and to participate in research initiatives such as MLS’s Data Registry. The team will also share with attendees how Miraca Life Sciences can help practices adopt an EHR and work toward achieving Meaningful Use compliance and prepare for ICD-10.
“Providing more than world-class hematopathology services, Miraca Life Sciences is experienced in collaborating with hematology and oncology practices to develop, implement and integrate technology solutions,” said Dan Kelly, Vice President of Client Connectivity at MLS. “At Miraca Life Sciences, we connect to a wide range of EHR systems and work with physicians every day—analyzing their workflows, examining technology options and recommending solutions. Since launching our fee-based technology consulting services, MLS has helped hundreds of practices as they navigate choosing and optimizing their EHR to achieve Meaningful Use compliance, prepare for ICD-10 and become interoperable.”
About Miraca Life Sciences
Miraca Life Sciences specializes in the development and commercialization of the highest quality academic pathology services, primarily in the fields of dermatology, hematology, gastroenterology and urology. The company’s core team of more than 90 academic-caliber specialists utilizes state-of-the-art pathology laboratories currently headquartered in Irving, Texas, and throughout the United States to serve more than 5,500 patients every day. Through rigorous quality assurance, daily and monthly conferences, and close relationships with clinical partners, Miraca Life Sciences continuously improves diagnostic precision.
The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Attendees of the 2014 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. Learn more online at am.asco.org. The event will be held May 30-June 3 in Chicago at McCormick Place.